Evidence map›Paper›PMID 26951200›Full record

ArticleMolecular and cellular biology2016

SUMOylation Regulates Growth Factor Independence 1 in Transcriptional Control and Hematopoiesis.

Daniel Andrade, Matthew Velinder, Jason Singer, Luke Maese, Diana Bareyan, Hong Nguyen, Mahesh B Chandrasekharan, Helena Lucente, David McClellan, David Jones and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Daniel AndradeDepartment of Oncological Sciences, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Matthew VelinderDepartment of Oncological Sciences, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Jason SingerDepartment of Oncological Sciences, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Luke MaeseDepartment of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah, USA Primary Children's Hospital, Salt Lake City, Utah, USA.
Diana BareyanDepartment of Oncological Sciences, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Hong NguyenDepartment of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Mahesh B ChandrasekharanDepartment of Radiation Oncology, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Helena LucenteDepartment of Oncological Sciences, University of Utah School of Medicine, Salt Lake City, Utah, USA.
David McClellanDepartment of Oncological Sciences, University of Utah School of Medicine, Salt Lake City, Utah, USA.
David JonesDepartment of Oncological Sciences, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Sunil SharmaDepartment of Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA Center for Investigational Therapeutics, Huntsman Cancer Institute, Salt Lake City, Utah, USA.
Fang LiuSusan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA.
Michael E EngelDepartment of Oncological Sciences, University of Utah School of Medicine, Salt Lake City, Utah, USA Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah, USA Primary Children's Hospital, Salt Lake City, Utah, USA Nuclear Control Program, Huntsman Cancer Institute, Salt Lake City, Utah, USA michael.engel@hci.utah.edu.
University of Utah · USPrimary Children's Hospital · USRutgers, The State University of New Jersey · USVanderbilt University · US

Funding

UTAH REGIONAL CANCER CENTERP30CA042014 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Jared P Rutter · 1986 to 2026
$72.6M
RESEARCH TRAINING IN HEMATOLOGYT32DK007115 · NIDDK · UNIVERSITY OF UTAH · PI LEIBOLD, ELIZABETH ANN, PRCHAL, JOSEF T · 1986 to 2020
$8.4M
Regulation of MTG16 and Notch signaling in hematopoiesisK08DK080190 · NIDDK · VANDERBILT UNIVERSITY · PI ENGEL, MICHAEL E · 2010 to 2014
$728k
NCI NIH HHS P30 CA042014NIDDK NIH HHS K08 DK080190NIDDK NIH HHS T32 DK007115
6 · The paper itself

Abstract

Cell fate specification requires precise coordination of transcription factors and their regulators to achieve fidelity and flexibility in lineage allocation. The transcriptional repressor growth factor independence 1 (GFI1) is comprised of conserved Snail/Slug/Gfi1 (SNAG) and zinc finger motifs separated by a linker region poorly conserved with GFI1B, its closest homolog. Moreover, GFI1 and GFI1B coordinate distinct developmental fates in hematopoiesis, suggesting that their functional differences may derive from structures within their linkers. We show a binding interface between the GFI1 linker and the SP-RING domain of PIAS3, an E3-SUMO (small ubiquitin-related modifier) ligase. The PIAS3 binding region in GFI1 contains a conserved type I SUMOylation consensus element, centered on lysine-239 (K239). In silico prediction algorithms identify K239 as the only high-probability site for SUMO modification. We show that GFI1 is modified by SUMO at K239. SUMOylation-resistant derivatives of GFI1 fail to complement Gfi1 depletion phenotypes in zebrafish primitive erythropoiesis and granulocytic differentiation in cultured human cells. LSD1/CoREST recruitment and MYC repression by GFI1 are profoundly impaired for SUMOylation-resistant GFI1 derivatives, while enforced expression of MYC blocks granulocytic differentiation. These findings suggest that SUMOylation within the GFI1 linker favors LSD1/CoREST recruitment and MYC repression to govern hematopoietic differentiation.

Indexed as

HematopoiesisAnimalsBinding SitesCell DifferentiationChlorocebus aethiopsCOS CellsGene Expression RegulationHEK293 CellsHistone DemethylasesHL-60 CellsHumansLysineMiceMolecular ChaperonesNIH 3T3 CellsProtein BindingGFI1B protein, humanHistone DemethylasesKDM1A protein, humanLysineMolecular ChaperonesMYC protein, humanPIAS3 protein, humanProtein Inhibitors of Activated STATProto-Oncogene ProteinsProto-Oncogene Proteins c-mycRepressor Proteins

Identifiers

PMID26951200
PMCPMC4859688
OpenAlexW2293660104

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.